Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis

During the ongoing COVID-19 pandemic due to the SARS-CoV-2 virus of which evidence-based medical paradigms cannot be easily applied; difficult clinical decisions shall be required particularly in the 'difficult-to-treat' cases of high risk group with associated comorbidities. Convalescent...

Descripción completa

Detalles Bibliográficos
Autores principales: Çınar, Olgu Erkin, Sayınalp, Başak, Aladağ Karakulak, Elifcan, Avşar Karataş, Ayşe, Velet, Mustafa, İnkaya, Ahmet Çağkan, Ersoy Ortaç, Nazmiye Ebru, Öcal, Serpil, Aksu, Salih, Haznedaroğlu, İbrahim Celalettin, Sayınalp, Nilgün, Özcebe, Osman İlhami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258803/
https://www.ncbi.nlm.nih.gov/pubmed/32487513
http://dx.doi.org/10.1016/j.transci.2020.102821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258803/
https://www.ncbi.nlm.nih.gov/pubmed/32487513
http://dx.doi.org/10.1016/j.transci.2020.102821

Ejemplares similares